Microsoft Q1: revenue of $24.54B, up 12% YoY, vs. $23.56B expected; net income up 16% YoY to $6.6B; Productivity revenue hits $8.2B, up 28% YoY
REDMOND, Wash. — October 26, 2017 — Microsoft Corp. today announced the following results for the quarter ended September 30, 2017:
Context & Ripple Effects
Microsoft closed its fiscal first quarter above Wall Street's bar — $24.54B against a $23.56B consensus — continuing the double-digit cadence set in the prior June quarter, when revenue rose 13% and net income more than doubled. The standout this time is the Productivity segment at $8.2B, up 28% year-over-year, evidence that the subscription conversion of Office is now compounding rather than cannibalizing license revenue.
The longer arc in the related coverage matters more than any single print: by the September 2020 quarter the same company reported $37.2B in revenue with Intelligent Cloud alone at $13.0B, up 20% — a segment that was still just $7.4B in mid-2017. This quarter sits early on that curve.
First-order effects
- Microsoft beats consensus by roughly $1B on revenue and grows net income 16% to $6.6B, with the Productivity segment's 28% jump doing the heavy lifting this quarter rather than Intelligent Cloud's 11% pace of the prior quarter.
Second-order effects
- The subscription-heavy Productivity result pressures rival office-suite vendors to match recurring-revenue economics, while the steady Intelligent Cloud build-up visible across the coverage — $7.4B in 2017 growing to $10.8B by late 2019 — keeps pricing pressure on infrastructure competitors.
Third-order effects
- If the pattern holds, Microsoft's reporting mix shifts structurally from one-time license sales to contracted recurring revenue, which smooths earnings visibility and lets the company fund cloud capacity ahead of demand — the dynamic the later quarters in this coverage confirm.
The trend: Enterprise software is migrating from licensed products to subscription and cloud consumption models, with Microsoft's quarterly prints from 2017 through 2020 tracing the compounding curve.